Breaking News

Katie Price’s son Harvey starts Ozempic injections to manage rare genetic condition

Harvey is diagnosed with Prader-Willi syndrome, a rare genetic disorder which causes constant hunger

Instagram @katieprice

Nuray Bulbul1 minute ago

Sign up to our free weekly newsletter for exclusive competitions, offers and theatre ticket deals

I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice.

Katie Price has revealed her son Harvey will start taking diet drug Ozempic due to worries over his increasing weight.

The former glamour model disclosed the decision was made after speaking with leading medical professionals.

Although Ozempic is usually used to treat diabetes, celebrities have increasingly started using them to lose weight.

She said that leading medical professionals have recommended these injections for Harvey, in the hope they will save – and enhance – his life.

Price acknowledged that things are “really serious” for Harvey and brought up the possibility that he might have a heart attack.

The mother of five openly admitted that Harvey isn’t currently losing weight because of a health condition called Prader-Willi syndrome, which is a rare genetic disorder that causes constant hunger.

In an interview with the Sun, she stated: “He’s putting on weight. It doesn’t matter what we do. He can’t put his shoes on without sweating. He can’t walk far because he gets out of breath.”

Harvey is also diagnosed with a number of other conditions, including oppositional defiant disorder, ADHD, autism, and septo-optic dysplasia.

Highlighting the challenges of managing the syndrome, Price claimed to have attempted a variety of methods, including consulting dieticians, to control her son’s weight.

“We’ve tried food, he’s had dietitians, it’s just the way he is,” she said.

As part of his treatment plan, doctors have advised Harvey to attempt the weight-loss injections for a maximum of two years. And, throughout the course of treatment, the medical staff will keep a close eye on Harvey’s development.

“The good thing about starting him on the drug is, if it has any effect, you can stop it because you do it weekly.

“They want to try him on it for at least one or two years, which is a long time, but they’ll control what level he needs then up it as they assess it,” Price explained.

Last month, the NHS said it is preparing for an increase in demand.

Read More